Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Ben Fidler Pharma Voice | ‘The bar has risen’: China’s biotech gains push US companies to adapt - about 2 months ago FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024 - about 2 months ago Wave sees RNA editing validation in early trial results - 5 months ago Medicare to cover Novo’s obesity drug for some patients - 12 months ago Biotech IPOs heated up to start 2024. Will the surge last? - 12 months ago BioMarin preaches patience amid slow sales for hemophilia gene therapy - about 1 year ago AstraZeneca, Daiichi aim for first pan-tumor ADC approval - about 1 year ago CRISPR eyes autoimmune disease in revamp of cell therapy plans - about 1 year ago | |
2 | Ned Pagliarulo Pharma Voice | Wave sees RNA editing validation in early trial results - 5 months ago | |
3 | Gwendolyn Wu Pharma Voice | Biotech IPOs heated up to start 2024. Will the surge last? - 12 months ago |